Bristol Myers sales fall, cuts 2023 forecast as drugs face competition

Previous article

Bristol Myers Slashes Forecast on Tumbling Revlimid Sales

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News